BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 14612560)

  • 1. Modulation of RNA editing by functional nucleolar sequestration of ADAR2.
    Sansam CL; Wells KS; Emeson RB
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14018-23. PubMed ID: 14612560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs.
    Vitali P; Basyuk E; Le Meur E; Bertrand E; Muscatelli F; Cavaillé J; Huttenhofer A
    J Cell Biol; 2005 Jun; 169(5):745-53. PubMed ID: 15939761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and sequence determinants required for the RNA editing of ADAR2 substrates.
    Dawson TR; Sansam CL; Emeson RB
    J Biol Chem; 2004 Feb; 279(6):4941-51. PubMed ID: 14660658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic association of RNA-editing enzymes with the nucleolus.
    Desterro JM; Keegan LP; Lafarga M; Berciano MT; O'Connell M; Carmo-Fonseca M
    J Cell Sci; 2003 May; 116(Pt 9):1805-18. PubMed ID: 12665561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site.
    Ohman M; Källman AM; Bass BL
    RNA; 2000 May; 6(5):687-97. PubMed ID: 10836790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain.
    Poulsen H; Jorgensen R; Heding A; Nielsen FC; Bonven B; Egebjerg J
    RNA; 2006 Jul; 12(7):1350-60. PubMed ID: 16682559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.
    Källman AM; Sahlin M; Ohman M
    Nucleic Acids Res; 2003 Aug; 31(16):4874-81. PubMed ID: 12907730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-dependent contribution of double-stranded RNA-binding motifs to ADAR2 function.
    Xu M; Wells KS; Emeson RB
    Mol Biol Cell; 2006 Jul; 17(7):3211-20. PubMed ID: 16672376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
    Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
    Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
    Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
    Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mismatch on binding of ADAR2/GluR-2 pre-mRNA complex.
    Yang J; Song J; Zhang JZ; Ji C
    J Mol Model; 2015 Sep; 21(9):222. PubMed ID: 26252972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate recognition by ADAR1 and ADAR2.
    Wong SK; Sato S; Lazinski DW
    RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editing of messenger RNA precursors and of tRNAs by adenosine to inosine conversion.
    Keller W; Wolf J; Gerber A
    FEBS Lett; 1999 Jun; 452(1-2):71-6. PubMed ID: 10376681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: conservation and diversity in editing site sequence and alternative splicing patterns.
    Slavov D; Gardiner K
    Gene; 2002 Oct; 299(1-2):83-94. PubMed ID: 12459255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The properties of a tRNA-specific adenosine deaminase from Drosophila melanogaster support an evolutionary link between pre-mRNA editing and tRNA modification.
    Keegan LP; Gerber AP; Brindle J; Leemans R; Gallo A; Keller W; O'Connell MA
    Mol Cell Biol; 2000 Feb; 20(3):825-33. PubMed ID: 10629039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a human tRNA-specific adenosine deaminase related to the ADAR family of pre-mRNA editing enzymes.
    Maas S; Gerber AP; Rich A
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8895-900. PubMed ID: 10430867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
    Lehmann KA; Bass BL
    Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases.
    Mizrahi RA; Phelps KJ; Ching AY; Beal PA
    Nucleic Acids Res; 2012 Oct; 40(19):9825-35. PubMed ID: 22885375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of ADAR-mediated RNA editing in newly identified targets.
    Riedmann EM; Schopoff S; Hartner JC; Jantsch MF
    RNA; 2008 Jun; 14(6):1110-8. PubMed ID: 18430892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
    Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
    Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.